Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties

Il Farmaco - Tập 59 Số 11 - Trang 863-868 - 2004
Hanna Wójtowicz‐Rajchel1, Krystian Kloc1, Irena Maliszewska1, Jacek Młochowski1, Marta Piętka1, E Piasecki2
1Institute of Organic Chemistry, Biochemistry and Biotechnology, Wrocław University of Technology, Wyb, Wyspiańskiego 27, 50-375 Wroclaw, Poland
2Laboratory of Virology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Muller, 1984, A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen), Biochem. Pharmacol., 33, 3235

Wendel, 1984, A novel biologically active seleno-organic compound II. Activity of PZ 51 in relation to glutathione peroxidase, Biochem. Pharmacol., 33, 3241, 10.1016/0006-2952(84)90084-4

Mugesh, 2001, The chemistry of biologically important organoselenium compounds, Chem. Rev., 101, 2125, 10.1021/cr000426w

Parnham, 1991, Pharmacology of synthetic organic selenium compounds, Prog. Drug Res., 38, 9

Schewe, 1995, Molecular actions of ebselen—an antiinflammatory antioxidant, Gen. Pharmac., 28, 1153, 10.1016/0306-3623(95)00003-J

Mugesh, 2000, Synthetic organoselenium compounds as antioxidants: glutathione peroxidase activity, Chem. Soc. Rev., 29, 347, 10.1039/a908114c

Inglot, 1990, Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes, Experientia, 46, 308, 10.1007/BF01951774

Młochowski, 1993, Aromatic and azaaromatic diselenides, benzisoselenazolones and related compounds as immunomodulators active in humans: synthesis and properties, Liebigs Ann. Chem., 1239, 10.1002/jlac.1993199301201

Inglot, 1996, Selenoorganic compounds as immunostimulants: an approach to the structure–activity relationship, Arc. Immunol. Ther. Exp., 44, 67

Zembowicz, 1993, Selective inhibition of endothelial nitric oxide synthase by ebselen, J. Pharmacol. Ther., 267, 1112

Hatchett, 1994, Carboxyebselen a potent and selective inhibitor of endothelial nitric oxide synthase, J. Physiol. Pharmacol., 45, 55

Młochowski, 1996, Synthesis and properties of 2-carboxyalkyl-1,2-benzisoselenazol-3(2H)-ones and related organoselenium compounds as nitric oxide synthase inhibitors and cytokine inducers, Liebigs Ann. Chem., 1751, 10.1002/jlac.199619961108

Osajda, 2001, Bisbenzisoselenazol-3(2H)-ones, a new group of ebselen analogues, Polish J. Chem., 75, 823

Palus, 2001, Synthesis of 2,2′-diselenobisbenzamides and 4,4′-diselenobutyramides with sulfamoyl groups as new potential virucides and cytokine inducers, Polish J. Chem., 75, 657

Wójtowicz, 2003, Functionalized alkyl and aryl diselenides and antimicrobial and antiviral agents: synthesis and properties, Il Farmaco, 58, 1235, 10.1016/j.farmac.2003.08.003

Bień, 1999, Antifungal activity of 2-(4-chlorophenyl)-1,2-benzisoselenazol-3(2H)-one, the analog of ebselen, Arch. Immun. Ther. Exp., 47, 185

Kloc, 2003, Synthesis of 7-azabenzisoselenazol-3(2H)- ones: a new group of selenium containing antimicrobials, Synthetic Commun., 33, 3805, 10.1081/SCC-120025191

Dzierzanowska, 2001, 40

Bistline, 1980, Fatty acids amides and anilides, J. Am. Oil Chem. Soc., 57, 98, 10.1007/BF02674376